128 related articles for article (PubMed ID: 36114049)
1. A population-based risk scoring system to individualize adjuvant treatment for stage IIIC endometrial cancer patients after surgery.
Yang XL; Zhang YE; Kou LN; Yang FL; Wu DJ
Eur J Surg Oncol; 2023 Feb; 49(2):475-480. PubMed ID: 36114049
[TBL] [Abstract][Full Text] [Related]
2. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
3. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
[TBL] [Abstract][Full Text] [Related]
4. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.
Binder PS; Kuroki LM; Zhao P; Cusworth S; Divine LM; Hagemann AR; McCourt CK; Thaker PH; Powell MA; Mutch DG; Massad LS
Gynecol Oncol; 2017 Nov; 147(2):309-314. PubMed ID: 28916118
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
6. Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients.
Yang XL; Yang FL; Kou LN; Wu DJ; Xie C
Front Endocrinol (Lausanne); 2022; 13():989063. PubMed ID: 36387854
[TBL] [Abstract][Full Text] [Related]
7. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemoradiotherapy versus chemotherapy alone in stage III endometrial cancer: A systematic review and meta-analysis.
Zhang G; Li H; Tian Z; Li X; Wang Z; Liang X; Wang Y; Shen X; Wang J
J Obstet Gynaecol Res; 2022 Jul; 48(7):1888-1896. PubMed ID: 35384146
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
10. A Scoring System to Select the Candidates for Adjuvant Chemotherapy Alone in High-Risk Early-Stage Cervical Cancer Patients With Pelvic Lymph Node Metastases After Surgery.
Yang XL; Yang FL; Wang N; Zhang YE; Kou LN; Wu DJ; Luo Y
Am J Clin Oncol; 2023 May; 46(5):219-224. PubMed ID: 36877193
[TBL] [Abstract][Full Text] [Related]
11. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
Jingjing H; Rui J; Hui P
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Adjuvant Chemoradiotherapy Versus Chemotherapy Alone for Stage III Endometrial Cancer: A Multicenter Retrospective Study.
Yoo JG; Kim JH; Kim CJ; Lee HN; Song MJ; Park DC; Yoon JH; Kim SI; Hur SY; Lee SJ
Cancer Control; 2022; 29():10732748221115288. PubMed ID: 35848426
[TBL] [Abstract][Full Text] [Related]
14. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
[TBL] [Abstract][Full Text] [Related]
15. Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
Kim HJ; Lee J; Lee KB; Sung K; Kim YB; Kim YS
Gynecol Oncol; 2024 Mar; 182():39-44. PubMed ID: 38246045
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH
Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
[TBL] [Abstract][Full Text] [Related]
17. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base.
Lester-Coll NH; Park HS; Rutter CE; Corso CD; Young MR; Ratner ES; Litkouhi B; Decker RH; Yu JB; Damast S
Gynecol Oncol; 2016 Jul; 142(1):54-61. PubMed ID: 27151429
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.
Albuquerque K; Folkert M; Mayadev J; Christie A; Liotta MR; Nagel C; Sevak P; Harkenrider MM; Lea JS; Hanna RK; Small WC; Miller DS; Xie XJ; Potkul RK; Elshaikh MA
Am J Clin Oncol; 2018 Aug; 41(8):792-796. PubMed ID: 28225446
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in endometrial cancer.
Gómez-Raposo C; Merino Salvador M; Aguayo Zamora C; Casado Saenz E
Cancer Chemother Pharmacol; 2020 Mar; 85(3):477-486. PubMed ID: 31950214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]